Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
Stopped Testing required by FDA for IND approval was too expensive to move forward with conduct of the study.
Conditions
- Recurrent Pregnancy Loss
- Miscarriage
Interventions
- DRUG: Hydroxychloroquine (HCQ)
- DRUG: Placebo
Sponsor
University of Utah
Collaborators